KR19980085889A - Obesity-controlled health food containing extracts of copper, red beans, multileaf and upper limb - Google Patents
Obesity-controlled health food containing extracts of copper, red beans, multileaf and upper limb Download PDFInfo
- Publication number
- KR19980085889A KR19980085889A KR1019970022067A KR19970022067A KR19980085889A KR 19980085889 A KR19980085889 A KR 19980085889A KR 1019970022067 A KR1019970022067 A KR 1019970022067A KR 19970022067 A KR19970022067 A KR 19970022067A KR 19980085889 A KR19980085889 A KR 19980085889A
- Authority
- KR
- South Korea
- Prior art keywords
- obesity
- powder
- multileaf
- composition
- health food
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title claims abstract description 37
- 235000020824 obesity Nutrition 0.000 title claims abstract description 37
- 210000001364 upper extremity Anatomy 0.000 title claims abstract description 20
- 235000013402 health food Nutrition 0.000 title claims abstract description 16
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 240000001417 Vigna umbellata Species 0.000 title claims abstract description 15
- 235000011453 Vigna umbellata Nutrition 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 title claims description 20
- 229910052802 copper Inorganic materials 0.000 title abstract description 10
- 239000010949 copper Substances 0.000 title abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 28
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 239000002075 main ingredient Substances 0.000 claims abstract description 8
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 6
- 235000013343 vitamin Nutrition 0.000 claims abstract description 6
- 239000011782 vitamin Substances 0.000 claims abstract description 6
- 229940088594 vitamin Drugs 0.000 claims abstract description 6
- 235000013361 beverage Nutrition 0.000 claims abstract description 4
- 235000021395 porridge Nutrition 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 5
- 241001107116 Castanospermum australe Species 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims description 3
- 235000004347 Perilla Nutrition 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000241413 Propolis Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000021279 black bean Nutrition 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 229940069949 propolis Drugs 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000283074 Equus asinus Species 0.000 claims 1
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 238000007602 hot air drying Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 7
- 241000411851 herbal medicine Species 0.000 abstract description 6
- 210000000577 adipose tissue Anatomy 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 235000012054 meals Nutrition 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 8
- 230000037213 diet Effects 0.000 description 7
- 235000019786 weight gain Nutrition 0.000 description 7
- 206010003210 Arteriosclerosis Diseases 0.000 description 6
- 208000011775 arteriosclerosis disease Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000004584 weight gain Effects 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 210000000579 abdominal fat Anatomy 0.000 description 3
- 235000019577 caloric intake Nutrition 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 235000012041 food component Nutrition 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YNVZDODIHZTHOZ-UHFFFAOYSA-K 2-hydroxypropanoate;iron(3+) Chemical compound [Fe+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O YNVZDODIHZTHOZ-UHFFFAOYSA-K 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000005118 dietary health Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2118—Garcinia cambogia, hydroxycitric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명에 따르면, 동과 팥, 다엽 및 상지를 주성분으로하고, 여기에 여러 생약제, 식품소재, 비타민 및 미네랄을 보조성분으로 함유하는 비만증 및 이에 따르는 각종 성인병을 억제, 예방할 수 있는 분말, 과립, 정제, 캡슐, 음료 및 죽 제품이 제공된다. 본 발명의 건강식품은 이를 섭취하며 식사량을 줄일 경우에도 사회생활에 지장을 주지 않고 효율적으로 체지방을 감소시킬 수 있다.According to the present invention, powders, granules, which can inhibit and prevent obesity and various adult diseases, including copper, red beans, multi-leaf and upper limb as main ingredients, and various herbal medicines, food materials, vitamins and minerals as auxiliary ingredients. Tablets, capsules, beverages and porridge products are provided. The health food of the present invention can efficiently reduce body fat even without reducing the amount of meals and does not interfere with social life.
Description
본 발명은 비만증의 조절을 위한 식이요법용 건강식품에 관한 것이다.The present invention relates to a dietary health food for the control of obesity.
국민경제가 발전함에 따라 에너지 함량이 높은 가공식품을 많이 섭취하고 운동량이 적어지면서 비만증이 국민건강을 위협하는 요인이 되고 있다. 비만증은 거북하고 아름답지 않은 외모로 보는 이에게 좋지 않은 이미지를 주고 활동에도 불편을 줄 뿐 아니라, 비만인은 정상인에 비하여 당뇨병, 동맥경화증, 고혈압증, 심장병, 간장병, 담석증, 통풍, 신장병 등의 발생률과 수술시 위험성이 높아 대체로 단명한다고 보고되고 있다. 따라서 비만증은 중년을 넘어선 사람에게는 생명에 관한 문제이며, 젊은 여성에게는 특히 미용상의 이유로 심각하게 고려되고 있다.As the national economy develops, obesity is becoming a threat to national health as people consume more processed foods with high energy content and have less exercise. Obesity not only gives a bad image and uncomfortable appearance to the viewer, but also obesity, and the obesity rate of diabetes, arteriosclerosis, hypertension, heart disease, liver disease, gallstones, gout, kidney disease, etc. It is reported that the risk of surgery is high and generally short-lived. Therefore, obesity is a life issue for those who are over the middle age, and is considered seriously for young women, especially for cosmetic reasons.
최근에 비만증과 같은 성인병의 예방 및 치료법으로서 적절한 운동과 더불어 오랜 세월 동안 안전성과 효능이 검증된 여러 식품소재의 이용에 대한 관심이 높아지고 있다. 현재 비만인을 위한 건강식품으로 식이섬유, 생약제 및 여러 식품소재를 함유하는 제품들이 개발되어 있으나, 식사량을 줄이고 이 제품들을 섭취할 경우 여러 영양소의 부족으로 인한 부작용으로 정상적인 생활이 어렵고, 복용을 중단하면 빠르게 다시 비만해지는 것으로 알려져 있다.Recently, with the appropriate exercise as a prevention and treatment of adult diseases such as obesity, there is a growing interest in the use of various food materials that have been proven safety and efficacy for many years. Currently, products containing dietary fiber, herbal medicines and various food ingredients have been developed as a health food for obese people.However, if you reduce the amount of meals and consume these products, normal life is difficult due to side effects due to lack of various nutrients. It is known to quickly become obese again.
본 발명자들은 비만증 및 이와 관련된 질환을 효율적으로 예방 및 억제할 수 있는 건강식품으로서, 이를 섭취하며 식사량을 줄이더라도 정상적인 사회생활에 지장을 주지 않고 효율적으로 체지방을 감소시킬 수 있으며, 상기 비만조절용 건강식품의 복용을 중단하더라도 일정 기간 내에는 다시 비만의 상태로 되돌어가지 않는 비만조절용 건강식품을 개발하고자, 각종 생약제, 기능성 식품소재, 비타민, 및 미네랄 등을 여러 비율로 배합하는 실험을 거듭하고, 그 효과를 실험으로 입증하여 본 발명을 완성하였다.The inventors of the present invention as a health food that can effectively prevent and suppress obesity and related diseases, even if ingested and reducing the amount of meals can effectively reduce body fat without disrupting normal social life, the health food for controlling obesity In order to develop obesity control health foods that do not return to the state of obesity within a certain period of time even if you stop taking, repeated experiments combining various herbal medicines, functional food materials, vitamins, and minerals in various ratios, The effect was demonstrated experimentally to complete the present invention.
즉, 본 발명에 따르면, 동과, 팥, 다엽 및 상지의 추출물에 여러 보조 성분을 첨가하여 부작용이 최소화된 비만조절용 건강식품 및 그의 제조방법이 제공된다.That is, according to the present invention, there is provided a health food for controlling obesity and a method of manufacturing the same, by minimizing side effects by adding various auxiliary ingredients to extracts of copper, red beans, multileaf and upper limb.
본 발명의 생약 성분 중 동과(冬瓜)는 수종(水腫) 및 간장질환을 치료하는 효과가 있고, 이뇨작용을 촉진시키며 대소장의 운동기능을 강화시킨다 [이시진, 본초강목, 고문사 (1987)]. 일반적으로 식이요법에 의한 비만증의 치료에는 이뇨기능 및 변비를 억제하는 대소장의 운동기능 강화가 필요하다고 알려져 있다 [과학백과사전 출판사, 장수의 건강학, 일월서각(1990)].Among the herbal components of the present invention, the gingiva is effective in treating several species and hepatic diseases, promotes diuretic action and strengthens the exercise function of the large intestine [Isijin, Herbal Tree, Torture History (1987)]. In general, it is known that dietary obesity requires strengthening the motor function of the small intestine, which suppresses diuretic function and constipation (Science Encyclopedia, Longevity Health, Ilwol Seokji (1990)).
팥은 수종과 소갈(消渴)의 억제 및 이뇨작용을 하며[허준, 동의보감, 남산당(1988)], 다엽(茶葉)은 황산화 작용이 있으며 심혈관 질환을 예방한다고 알려져 있다 [Biol, Pharm. Bull. 18, 1006(1995)]. 또한 상지(桑枝)는 이뇨작용과 고혈압의 억제 작용이 있다[新文豊出版公司 新編 中藥大辭典, 臺北 (中華民國 71年)].Red beans act as a suppressant and diuretic effect of tree species and sorghum (Heo Jun, Dong Bogam, Namsan Dang (1988)), and tea leaves have sulfate action and prevent cardiovascular disease [Biol, Pharm. Bull. 18, 1006 (1995). In addition, the upper limb has a diuretic effect and hypertension suppression [新 文 豊 出版 公司 新編 中藥 大 辭典, 臺北 (中華民國 71 年)].
본 발명을 이하에 보다 상세히 설명한다.The present invention is explained in more detail below.
본 발명의 주원료의 하나인 동과는 이물질을 제거한 후 껍질 및 씨와 함께 동결, 건조 또는 40 - 80℃에서 열풍건조하여 분말화하거나, 씨만 제거한 후 생체를 자르거나 갈아서 사용한다. 동과를 잘라서 사용할 경우에는 조각의 크기가 3 mm 이하이도록 절단하는 것이 바람직하다. 팥은 삶아서 그 즙과 함께 건조시켜 분쇄한다. 다엽은 건조시켜 분쇄하여 사용하거나, 열수추출하여 감압농축하 뒤 40%의 덱스트린을 첨가해서 분말화하여 사용한다. 상지는 상지편의 표면이 미황색이 되도록 볶아서 사용하거나, 볶은 뒤 다엽과 같은 방법으로 열수추출하고 감압농축한 뒤 분말화해서 사용한다.Copper, one of the main raw materials of the present invention is freeze, dried or hot-air dried at 40-80 ° C. together with the skin and seeds after removing foreign matters, or only the seeds are removed and used to cut or grind the living body. When cutting and using the copper fruit, it is preferable to cut so that the size of a piece may be 3 mm or less. The red beans are boiled, dried together with the juice and crushed. The multileaf is dried and ground to use, or hot water extracted and concentrated under reduced pressure, followed by powdering by adding 40% dextrin. The upper limbs are roasted so that the surface of the upper limb is pale yellow, or hot water extracted in the same way as the multileaf after roasting, concentrated under reduced pressure, and powdered.
본 발명에 따르는 비만조절용 건강식품에 배합되는 상기 주성분의 양은, 중량 기준으로, 동과 생체 40 - 90% 또는 동과 분말 10 - 60%, 팥 2 - 40%, 다엽 5 - 25% 또는 다엽 추출물 분말 1 - 6%, 볶은 상지 5 - 30% 또는 상지 추출물 분말 1 - 15%이 바람직하다.The amount of the main ingredient to be blended in the obesity control health food according to the present invention, based on weight, 40 to 90% copper and 10 to 60% copper powder, 2 to 40% red beans, 5 to 25% or multi-leaf extract Preference is given to 1-6% of powder, 5-30% of roasted upper extremity or 1-15% of upper extremity extract powder.
상기 건강식품의 보조성분으로서는 다시마, 검정콩, 들깨, 키토산, 가르시니아 캄보지아 추출물, 당귀, 프로폴리스, 송엽, 효모, 석창포, 대추, 천문동, 백복령, 율무, 비타민, 미네랄 등을 적정량 포함할 수 있으며, 바람직하게는 건강식품 총 중량의 10% 내지 80%의 양으로 포함되는 것이 좋다. 보조성분은 통상의 방법으로 추출 또는 분쇄하거나, 통상의 건강식품이나 생약재에 사용되는 것과 같은 방법 및 상태로 사용된다. 다시마는 물에 담가 염분을 제거한 후 건조하여 분쇄한다.Auxiliary components of the health food may include an appropriate amount of kelp, black beans, perilla, chitosan, garcinia cambogia extract, Angelica, propolis, pine needles, yeast, Seokchangpo, jujube, astronomical dong, baekbokyeong, yulmu, vitamins, minerals, etc., preferably Preferably it is included in an amount of 10% to 80% of the total weight of the health food. Auxiliary ingredients are extracted or pulverized by conventional methods or used in the same methods and conditions as those used in conventional health foods or herbal medicines. Kelp is immersed in water to remove salt and then dried and crushed.
본 발명의 건강식품 조성물에 함유되는 주성분 및 보조성분은 모두 예로부터 생약재, 식품재료 및 식품 또는 의약첨가물로 사용되어 온 것이므로, 복용 또는 섭취시 인체에 대한 안전성이 우수하다.Since the main ingredient and the auxiliary ingredient contained in the health food composition of the present invention have all been used as herbal medicines, food ingredients and food or pharmaceutical additives since ancient times, safety of the human body is excellent when taken or ingested.
본 발명에 따른 조성물은 통상의 방법에 따라 분말화하거나, 추출하여 캡슐, 정제, 과립, 분말, 음료, 죽 등의 형태로 제형화할 수 있다.The composition according to the present invention may be powdered or extracted according to a conventional method and formulated in the form of capsules, tablets, granules, powders, beverages, porridges and the like.
이하, 실시예에 의해 본 발명을 보다 상세히 설명하지만 본 발명이 이들 실시예에 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.
[실시예]EXAMPLE
[실시예 1]Example 1
동과는 이물질을 제거한 후 세절하여 껍질 및 씨와 함께 80℃에서 열풍건조하여 분말화하였다. 상지는 상지편의 표면이 미황색이 되도록 볶은 뒤 열수추출하고 감압농축한 뒤 40%의 덱스트린을 가하여 분말화하였다. 팥은 삶아서 그 즙과 함께 건조시켜 분말화하였다. 다엽은 건조시켜 분쇄하였다.After removing foreign matters, the fruit was cut into small pieces and dried in hot air at 80 ° C. together with shells and seeds to powder. The upper limb was roasted to make the surface of the upper limb pale yellow, hot water extracted, concentrated under reduced pressure, and powdered by adding 40% dextrin. The red beans were boiled, dried with the juice and powdered. The multileaf was dried and ground.
[실시예 2]Example 2
동과 분말 25%, 팥 10%, 다엽 추출물 분말 2%, 상지 추출물 분말 5%, 다시마 2%, 볶은 검정콩 23%, 볶은 들깨 11%, 볶은 율무 13%, 백복령 5%, 비타민 및 미네랄 혼합물 4%를 혼합하여 분말을 제조하였다. [비타민-미네랄 혼합물의 조성(%): 비타민 A 0.05, 비타민 C 12.9, 비타민 D 0.0003, 비타민 B10.09, 비타민 B20.1, 비타민 B60.1, 비타민 B120.0003, 엽산 0.01, 나이아신 1.2, 해조칼슘 36.5, 염화 마그네슘 47.6, 젖산 철 0.9, 산화 아연 0.5]Copper powder 25%, Red beans 10%, Multileaf extract powder 2%, Upper lichen extract powder 5%, Kelp 2%, Roasted black beans 23%, Roasted perilla 11%, Roasted roasted radish 13%, Baekboknyeong 5%, Vitamin and mineral mixture 4 The powder was prepared by mixing the%. [Composition of vitamin-mineral mixture (%): vitamin A 0.05, vitamin C 12.9, vitamin D 0.0003, vitamin B 1 0.09, vitamin B 2 0.1, vitamin B 6 0.1, vitamin B 12 0.0003, folic acid 0.01, niacin 1.2, seaweed Calcium 36.5, magnesium chloride 47.6, iron lactate 0.9, zinc oxide 0.5]
[실시예 3]Example 3
동과 분말 25%, 상기 추출물 분말 5%, 다엽 추출물 분말 3%, 팥 10%, 석창포 추출물 분말 5%, 천문동 5%, 가르시니아 캄보지아 추출물 (수산화구연산 68%) 5%, 백복령 5%, 율무 10%, 송엽 5%, 프로폴리스 5%, 당귀 추출물 3%, 비타민-미네랄 혼합물 12% 및 효모 2%를 혼합하여 통상의 방법에 따라 과립을 제조하였다. [비타민-미네랄 혼합물의 조성은 실시예 2와 동일]Copper fruit powder 25%, the extract powder 5%, multi-leaf extract powder 3%, red beans 10%, Seokchangpo extract powder 5%, cheonmundong 5%, Garcinia cambogia extract (68% citric acid hydroxide) 5%, Baekbokyeong 5%, Yulmu 10 Granules were prepared according to a conventional method by mixing%, pine needles 5%, propolis 5%, Angelica extract 3%, vitamin-mineral mixture 12% and yeast 2%. [The composition of the vitamin-mineral mixture is the same as in Example 2]
[실시예 4]Example 4
실시예 2에서 제조한 과립을 통상의 방법에 따라 타정하여 정제(각 200 mg)를 수득하였다.The granules prepared in Example 2 were compressed into tablets according to a conventional method to obtain tablets (200 mg each).
[실시예 5]Example 5
상기 실시예 1에서 수득된 분말을 경질 젤라틴 캡슐(각 400mg)에 충전하였다.The powder obtained in Example 1 was filled into hard gelatin capsules (400 mg each).
[실시예 6]Example 6
동과 생체 55%, 상지편 10%, 다엽 10%, 팥 5%, 대추 10% 및 비타민-미네랄 혼합물 10%의 원료 혼합물에 20배의 물을 가하고 70℃에서 1시간 추출하였다. [비타민-미네랄 혼합물의 조성은 실시예 2와 동일] 원심분리 후 고형분에 다시 20배의 물을 가하여 동일한 조건에서 추출한 후 원심분리하였다. 고체 잔류물을 버리고 두 추출액을 합쳐 50℃에서 감압(30 - 50 mmHg)농축하여 추출전 조성물 중량의 2배가 되게 하고 3 미크론 필터로 여과하여 75 - 80℃에서 30분간 멸균시킨 후 200메쉬의 여과장치를 통과시켜 여액을 미리 살균된 용기에 충전밀봉하여 음료로 한다.20 times of water was added to a raw material mixture of 55% of living animals, 55% of upper limbs, 10% of multilobes, 5% of red beans, 10% of jujubes, and 10% of vitamin-mineral mixtures, and extracted at 70 ° C. for 1 hour. [The composition of the vitamin-mineral mixture is the same as in Example 2] After centrifugation, 20 times of water was added to the solid, extracted under the same conditions, and centrifuged. Discard the solid residue, combine the two extracts and concentrate under reduced pressure (30-50 mmHg) at 50 ° C to double the weight of the composition before extraction, filter with a 3 micron filter and sterilize at 75-80 ° C for 30 minutes, then filter 200 mesh Through the device, the filtrate is filled and sealed in a pre-sterilized container to be a beverage.
[실시예 7]Example 7
3 mm 이하의 크기로 자른 동과 생체 83%, 다엽 추출물 분말 1%, 상지 추출물 분말 2%, 삶은 팥 4%, 율무 4%, 다시마 분말 2%, 쌀 4% 및 비타민-미네랄 혼합물 10%의 조성으로 통상의 방법에 따라 죽을 제조하였다. [비타민-미네랄 혼합물의 조성은 실시예 2와 동일]83% of copper and biomedium cut to 3 mm or less, multi-leaf extract powder 1%, upper extremity extract powder 2%, boiled red beans 4%, red radish 4%, kelp powder 2%, rice 4% and vitamin-mineral mixture 10% The porridge was prepared according to a conventional method by the composition. [The composition of the vitamin-mineral mixture is the same as in Example 2]
[실험예 1]Experimental Example 1
비만증 억제효과 실험 (동물실험)Obesity Inhibitory Effect Experiment (Animal Experiment)
(1) 동물실험(1) animal experiment
본 실험에 사용된 동물은 웅성 스프래그-다울리(Sprague-Dawley)계 흰쥐였다. 4주령의 쥐를 구입하여 1주간 시판 펠렛(pellet) 사료을 급여한 뒤 10마리씩 군을 나누었다. 정상 대조군은 계속 펠렛 사료만 주고 나머지 모든 군은 펠렛 사료와 함께 사람에게 가장 흔히 발생하는 비만유형과 가장 가까운 비만증을 유발한다고 알려진 카페테리아 다이어트(cafeteria diet)를 급여하였으며, 모든 사료와 물을 자유섭취시켰다. 카페테리아 다이어트를 2주간 급여한 후, 본 발명의 실시예1에서 수득된 건강식품의 주원료 각 성분, 및 상기 네 성분의 혼합물에 증류수를 넣고 혼합하여 0.4 ml가 되게 하여 하루 2회 각각 경구투여하였으며, 대조군은 동 부피의 생리식염수를 경구투여하였다. 6주간 카페테리아 다이어트를 급여하면서 시료를 경구투여하였는데, 시료의 투여량은 사람의 1일 사용량과 사람과 쥐의 체중비율로부터 환산하였다. 카페테리아 다이어트로 쿠키, 비스켓, 쵸콜렛, 땅콩, 치즈, 감자칩, 아몬드, 소세지 및 햄을 급여하였다.The animals used in this experiment were male Sprague-Dawley rats. Four-week-old rats were purchased, fed a commercial pellet feed for one week, and then divided into 10 groups. The normal control group continued to feed only pellets and all other groups fed the pellets with a cafeteria diet, which is known to cause obesity closest to the most common types of obesity in humans, and freed up all feed and water. . After feeding the cafeteria diet for 2 weeks, distilled water was added to each of the main ingredients of the health food obtained in Example 1 of the present invention, and a mixture of the four ingredients, so that the mixture was 0.4 ml, and orally administered twice a day. The control group was orally administered the same volume of saline. Samples were administered orally with a 6-week cafeteria diet. The doses were converted from the daily use of humans and the weight ratio of humans and rats. The cafeteria diet was fed cookies, biscuits, chocolate, peanuts, cheese, potato chips, almonds, sausages and ham.
시료를 6주간 경구투여한 후 심장에서 혈액을 체취하고, 간, 신장 지방조직(perirenal fat pad) 및 정소상체 지방조직(epididymal fat pad)을 잘라내어 무게를 측정하였다.After oral administration of the sample for 6 weeks, blood was collected from the heart, and liver, kidney fat tissue (perirenal fat pad) and epididymal fat tissue (epididymal fat pad) were cut and weighed.
(2) 화학분석(2) chemical analysis
간의 중성지질을 분석하기 위하여 간의 지질을 추출한 뒤 효소법으로 중성지질을 정량하였다. 혈청의 총 콜레스테롤, HDL-콜레스테롤 및 포도당 함량은 드라이 케미스트리 시스템(dry chemistry system, 일본 Daiichi사 제품)을 이용하여 분석하였다.To analyze hepatic triglycerides, hepatic lipids were extracted and neutral lipids were quantified by enzyme method. Serum total cholesterol, HDL-cholesterol and glucose content were analyzed using a dry chemistry system (manufactured by Daiichi, Japan).
(3) 시험결과(3) Test result
실시예 1에 따르는 건강식품 주성분의 비만증 억제기능 조사 결과를 다음 표 1 에 나타내었다. 비만 대조군에 비하여, 4종의 주성분 중 동과 분말이 체중 증가량을 6% 감소시켰으며 열량섭취도 감소시켰다. 네 성분 모두 복부 지방의 축적을 억제하였으며, 다엽 분말과 상지 추출물이 간의 중성지방 축적을 억제하였다. 팥 분말과 상지 추출물이 혈당 농도를 감소시켰고, 동과 분말, 다엽분말 및 상지 추출물이 비만 대조군에 비하여 동맥경화 위험지수를 감소시켰는데 다엽 분말의 효과가 더욱 커서 정상 대조군과 같은 수준까지 감소시켰다. 4종의 주성분을 함께 급여한 경우 체중 증가량이 비만 대조군에 비하여 10% 감소하여 동과 분말만 급여한 경우보다 체중 증가가 더욱 크게 억제되었으며 다른 모든 측정치도 한 성분만을 급여한 경우 보다 낮아져서 간의 중성지방 함량, 동맥경화 위험지수 및 혈당 농도가 정상 대조군과 같은 수준으로 되었다. 이상의 결과는 동과 분말, 팥 분말, 다엽 분말 및 상지 추출물이 모두 각각 체중 증가를 억제하여 비만증을 억제할 수 있을 뿐 아니라, 열량 섭취, 복부지방 축적 및 동맥경화 위험지수를 감소시킬 수 있음을 입증하여 준다. 뿐만 아니라, 상기의 네 성분이 일정 비율로 조합되었을 대, 조성물의 비만증 및 이에 관련된 성인병 억제 효과는 더욱 상승하여 더욱 효율적으로 비만증 및 이와 관련된 질환인 지방간, 동맥경화, 그리고 당뇨병을 억제할 수 있음을 보여주고 있다.The results of the obesity inhibitory function of the health food main ingredient according to Example 1 are shown in Table 1 below. Compared with the obese control group, copper and powder among the four main components reduced the weight gain by 6% and the caloric intake. All four components inhibited abdominal fat accumulation, and multileaf powder and upper limb extract inhibited liver triglyceride accumulation. Red bean powder and upper extremity extracts decreased blood sugar levels, and copper powder, multileaf powder and upper extremity extracts reduced the risk of arteriosclerosis compared to the obese control group. When the four main ingredients were fed together, the weight gain decreased by 10% compared to the obese control group, and the weight gain was more suppressed than the copper and powder only diet, and all other measures were lower than the one ingredient alone. Content, arteriosclerosis risk index and blood glucose level were the same as the normal control. These results demonstrate that copper powder, red bean powder, multi-leaf powder and upper limb extract can all suppress weight gain and suppress obesity, as well as reduce calorie intake, abdominal fat accumulation and atherosclerosis risk index. Give it. In addition, when the above four components are combined in a certain ratio, the effect of inhibiting the obesity and related diseases of the composition of the composition is further increased to more effectively inhibit obesity and related diseases such as fatty liver, arteriosclerosis, and diabetes mellitus. Is showing.
[표 1]TABLE 1
비만증 억제효과1 Obesity inhibitory effect 1
1. 평균치 ± SE(표준오차). 1군당 10마리. 같은 칼럼에서 서로 다른 위첨자를 갖는 값들은 유의차가 있음. (P0.05)1. Mean ± SE (standard error). 10 per group. Values with different superscripts in the same column are significantly different. (P0.05)
2. 도살전 5일간 측정2. 5 days before slaughter
3. (총 콜레스테롤 - HDL - 콜레스테롤) / HDL-콜레스테롤3. (Total Cholesterol-HDL-Cholesterol) / HDL-Cholesterol
또한 본 발명의 실시예 2, 3, 4, 6, 7에서 제조된 조성불의 비만증 억제기능 조사 결과를 하기 표 2 에 나타내었다. 본 발명의 조성물이 부여된 모든 군이 비만대조군에 비하여 유의성있게 체중 증가, 열량 섭취, 복부지방 축적 및 간의 중성지방 축적을 억제하였고, 동맥경화 위험지수와 혈당농도도 감소시켰다. 이러한 결과는 각 실시예에서 제조된 조성물들이 비만증 및 이와 관련된 질환인 지방간, 동맥경화, 그리고 당뇨병을 효율적으로 억제할 수 있음을 입증하는 것이다. 특히, 실시예 2와 실시예 3에 따르는 조성물을 섭취하는 경우에는 비만 대조군과 같은 카페테리아 다이어트 시료를 급여하였음에도 불구하고 체중증가나 체지방 등의 요인이 비만증을 유발하지 않은 정상 대조군과 필적할 정도로 억제되었음을 알 수 있다.In addition, the results of investigation of the anti-obesity function of the composition prepared in Examples 2, 3, 4, 6, and 7 of the present invention are shown in Table 2 below. All groups given the composition of the present invention significantly inhibited weight gain, calorie intake, abdominal fat accumulation and hepatic triglyceride accumulation as compared to the obesity control group, and also reduced atherosclerosis risk index and blood glucose concentration. These results demonstrate that the compositions prepared in each example can effectively inhibit obesity and related diseases such as fatty liver, arteriosclerosis, and diabetes. In particular, ingesting the composition according to Examples 2 and 3, despite the fact that the diet was fed a cafeteria diet sample, such as the obesity control, factors such as weight gain and body fat were inhibited to the extent comparable to the normal control did not cause obesity Able to know.
[표 2]TABLE 2
비만증 억제효과 실험 결과1 Obesity Inhibitory Effect Experiment Results 1
1. 평균 ± SE(표준오차). 1군당 10마리. 같은 칼럼에서 서로 다른 위첨자를 갖는 값들은 유의차가 있음 (P0.05)1. Mean ± SE (standard error). 10 per group. Values with different superscripts in the same column are significantly different (P0.05)
2. 도살전 5일간 측정2. 5 days before slaughter
3. (총 콜레스테롤 - HDL - 콜레스테롤) / HDL-콜레스테롤3. (Total Cholesterol-HDL-Cholesterol) / HDL-Cholesterol
[실험예 2]Experimental Example 2
비만증 억제효과 실험 (임상실험)Obesity Inhibitory Effect Experiment (Clinical Experiment)
표준 체중 (kg) = [신장(cm) - 100] × 0.9Standard weight (kg) = [height (cm)-100] × 0.9
비만도(%) = (실제체중 - 표준체중)/(표준체중) × 100Obesity degree (%) = (actual weight-standard weight) / (standard weight) × 100
위의 두 공식에 의하여 계산된 비만도 30% 이상의 성인 남녀 각 5인에게 아침과 점심 식사 전에 실시예 3에 따르는 과립제를 각 8 g 씩 섭취시키고 저녁에는 실시예 2에 따르는 분말을 40 g 씩 섭취시켰다. 이렇게 28일간 섭취시킨 결과 체중이 섭취 전에 비하여 평균 3.64 kg 감소시켰다. 또한 섭취 중단 후 28일간 체중 증가량은 평균 0.72 kg 이었다. 이러한 결과는 본 발명의 비만조절용 건강식품 조성물이 사람의 비만증을 매우 효과적으로 억제할 수 있으며, 섭취를 중단할 경우 빠르게 체중이 증가하는 요요현상도 나타나지 않음을 입증하는 것이다.Five adult men and women with obesity of 30% or more calculated by the above two formulas were given 8 g of granules according to Example 3 before breakfast and lunch, and 40 g of powder according to Example 2 in the evening. . The 28-day intake resulted in an average weight loss of 3.64 kg compared to before consumption. In addition, the average body weight gain for 28 days after ingestion was 0.72 kg. These results prove that the obesity control health food composition of the present invention can effectively suppress obesity in humans, and when the intake is stopped, yoyo phenomena that rapidly gain weight do not appear.
동과, 팥, 다엽 및 상지를 주성분으로 하고 생약재, 식품소재, 비타민 및 미네랄을 보조성분으로 함유하는 본 발명의 비만조절용 건강식품 조성물 상기 실험예들의 결과에서 나타난 바와 같이 비만증은 물론, 이와 관련된 질환인 지방간, 동맥경화, 그리고 당뇨병을 효율적으로 억제해준다.Obesity control as well as diseases associated with obesity, as shown in the results of the above experiments, as shown in the results of the experimental examples, the main ingredient of the fruit, red bean, multi-leaf and upper limb and containing herbal medicines, food ingredients, vitamins and minerals as auxiliary ingredients Phosphorus effectively suppresses fatty liver, arteriosclerosis, and diabetes.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970022067A KR100237168B1 (en) | 1997-05-30 | 1997-05-30 | Obesity-controlling health food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970022067A KR100237168B1 (en) | 1997-05-30 | 1997-05-30 | Obesity-controlling health food |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19980085889A true KR19980085889A (en) | 1998-12-05 |
KR100237168B1 KR100237168B1 (en) | 2000-01-15 |
Family
ID=19507958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970022067A KR100237168B1 (en) | 1997-05-30 | 1997-05-30 | Obesity-controlling health food |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100237168B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020034132A (en) * | 2002-04-10 | 2002-05-08 | 강헌수 | adzuki bean extract for food and their manufacturing method and food composition contained adzuki bean extract |
KR100672141B1 (en) * | 2000-12-05 | 2007-01-19 | 가부시끼가이샤 엔도세이안 | Healthy drink made from azuki beans and it's production method |
KR100728055B1 (en) * | 2005-02-24 | 2007-06-13 | (주)바이오뉴트리젠 | food for preventing fatness and hyperlipemia |
KR100734609B1 (en) * | 2006-04-21 | 2007-07-03 | 주식회사 동원고려인삼 | Process for preparing pill-type wax gourd |
KR100785367B1 (en) * | 2006-06-27 | 2007-12-18 | 충청북도 | Method for preparing insoluble fiber from soy hull |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100484597B1 (en) * | 1997-06-21 | 2005-08-29 | 씨제이 주식회사 | Camellia and extracts for the treatment of gastrointestinal disorders and beverages containing them |
KR20170001491A (en) | 2015-06-26 | 2017-01-04 | 이승현 | Method for preparing a beverage using benincasa hispida |
KR101876805B1 (en) | 2016-10-18 | 2018-07-10 | 고려대학교 산학협력단 | The composition containing the ethanol extracts of Ramulus mori for preventing or treating obesity |
-
1997
- 1997-05-30 KR KR1019970022067A patent/KR100237168B1/en not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100672141B1 (en) * | 2000-12-05 | 2007-01-19 | 가부시끼가이샤 엔도세이안 | Healthy drink made from azuki beans and it's production method |
KR20020034132A (en) * | 2002-04-10 | 2002-05-08 | 강헌수 | adzuki bean extract for food and their manufacturing method and food composition contained adzuki bean extract |
KR100728055B1 (en) * | 2005-02-24 | 2007-06-13 | (주)바이오뉴트리젠 | food for preventing fatness and hyperlipemia |
KR100734609B1 (en) * | 2006-04-21 | 2007-07-03 | 주식회사 동원고려인삼 | Process for preparing pill-type wax gourd |
KR100785367B1 (en) * | 2006-06-27 | 2007-12-18 | 충청북도 | Method for preparing insoluble fiber from soy hull |
Also Published As
Publication number | Publication date |
---|---|
KR100237168B1 (en) | 2000-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100645385B1 (en) | Composition for anti-obesity | |
CN108850366A (en) | A kind of alternative tea composition and preparation method thereof with anti-trioxypurine effect | |
KR101738912B1 (en) | Composition For Anti-obesity And Diet | |
KR100649128B1 (en) | Manufacturing method of functional food composition including maesil | |
KR100237168B1 (en) | Obesity-controlling health food | |
CN106982885A (en) | A kind of arhat fruit cookie and preparation method thereof | |
KR20040095949A (en) | Composition comprising herb with usage to prevent obeseness | |
KR100336644B1 (en) | The composites of raw-type tea with anti-obese function | |
KR102422527B1 (en) | Supplement food composition for diet | |
CN106999532A (en) | The enhancing of Motor execution ability and physical enhancement composition containing composite extract | |
KR20200016608A (en) | The health food composition for regulating weight | |
CN112544767A (en) | Preparation method of selenium-rich tabletted candy | |
EP1583547B1 (en) | Anti-obesity ingredients from medicinal plants and their composition | |
JP3489095B2 (en) | Health foods and beverages | |
JP4549486B2 (en) | Anti-obesity drug and method for producing the same | |
KR100293890B1 (en) | Food composition for control of body weight and blood sugar prepared by using Dong-A Green Juice and its residue | |
RU2533040C2 (en) | Composition for phytojam preparation (versions) | |
JP2004352626A (en) | Anticholesterol agent containing plant-derived component | |
KR20200043555A (en) | Supplement food composition for diet | |
JP2004329047A (en) | Dietary supplement | |
JPH0767576A (en) | Healthy edible material of mycelium | |
CN105101817A (en) | Edible composition, preparation method therefor, and food product comprising the composition | |
KR20050068289A (en) | Manufacturing method of functional berverage and food by using wax gourd,flavonoid and honey | |
JP2001046019A (en) | Nutritive composition originated from citrus fruit | |
JP2020137496A (en) | Composition containing mulberry leaf processed product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20091006 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |